TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
OCUL

Ocular Therapeutix Inc

Healthcare · Biotechnology

9.70$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -205 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OCUL
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13 -13 -20 -34 -34 -50 -49 -78 -54 -66 -60 -70 -135 -205
0.4 0.4 0.5 0.8 0.9 1.6 2.3 2.5 2.8 2.4 2.1 3.0 3.8 4.3
0.2 0.5 2.6 4.6 6.0 7.3 7.5 8.8 7.5 15 17 18 33 43
– – 2.6 4.3 7.2 7.3 7.5 4.5 94 -59 3.1 – – –
0.7 -0.2 2.2 0.5 2.1 3.6 0.6 -1.9 1.2 -2.9 1.3 -7.4 -10 7.7
0.2 0.4 1.3 1.8 1.9 8.3 1.9 2.2 0.8 1.2 3.7 6.1 1.3 12
3.8 -0.4 -39 -39 36 27 -1.9 -2.2 -0.8 -1.2 -3.7 -6.1 -1.3 -12
– – 15 2.1 0.0 4.4 0.3 37 0.7 0.7 – 53 – –
– – 0.1 0.2 1.1 0.3 0.3 0.5 0.7 1.0 0.9 0.9 1.0 1.6
– – 12 0.4 2.4 2.4 6.4 37 -0.4 -0.4 0.0 56 0.0 0.0
27 6.7 79 66 0.6 32 69 75 228 2.9 1.5 170 332 562
19 -6.3 20 -6.6 2.2 8.6 18 -4.5 174 -64 -62 94 196 345
-13 -13 -22 -36 -36 -59 -51 -80 -54 -67 -63 -76 -136 -217

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?